baber/WOPTO huggingface dataset:
Patent AU-2015298294-B2 (AU)
Title: Hand-forming card shuffling apparatuses including multi-card storage compartments, and related methods
Inventor: STASSON JAMES B
IPC: A63F1/12
Filed: 2015-07-13
Granted: 2018-07-05
Abstract: Card shufflers usable in forming and dispensing randomized playing card hands for use in playing card games include a card input mechanism for inputting cards into the card shuffler, a card storage device for receiving cards from the card input mechanism and temporarily storing cards within the card shuffler, and a card output mechanism for outputting shuffled cards from the card shuffler. The card storage device may include a wheel configured to rotate within the card shuffler. The rotatable wheel may have a plurality of card storage compartments therein, each of which may be sized and configured to hold two or more cards therein. Related methods involve the use of such card shufflers in playing card games.
Patent AU-2015362737-B2 (AU)
Title: Techniques for reserving a channel of a radio frequency spectrum
Inventor: YERRAMALLI SRINIVAS
IPC: H04W74/08
Filed: 2015-12-15
Granted: 2019-02-28
Abstract: Techniques are described for wireless communication. A first method includes contending for access to a first channel of a radio frequency spectrum, and transmitting, upon winning contention for access to the first channel, a first channel reservation indication. The contending may be performed by a first node operating according to a first radio access technology. The first channel reservation indication may be understood by a second node operating according to a second radio access technology.
Patent AU-2015374527-B2 (AU)
Title: Fabric adhesion to an apparatus
Inventor: NELSON JOHN JACOB
IPC: G06F3/02
Filed: 2015-12-07
Granted: 2020-07-16
Abstract: Techniques for fabric adhesion to an apparatus are described. According to one or more embodiments, an apparatus is laminated with fabric utilizing one or more fabric layers. In at least some embodiments, multiple adhesive zones are defined on a fabric layer. Each adhesive zone, for instance, has a particular set of properties, such as a particular location on a fabric layer, a particular adhesive thickness, a particular adhesive type, and so forth. In at least some embodiments, different adhesive zones differ from one another based on one or more of their respective properties and thus enable different fabric characteristics to be specified at different adhesive zones.
Patent AU-2015383110-B2 (AU)
Title: Dual-frequency tags to detect cement curing in wellbore applications
Inventor: ROBERSON MARK
IPC: E21B47/00
Filed: 2015-02-20
Granted: 2018-04-05
Abstract: Micro-Electro-Mechanical System ("MEMS") tags having high and low resonant frequencies are used to detect the cured or uncured state of wellbore cement. The MEMS tags may be added to wellbore cement, and pumped downhole. An interrogation tool emits a signal at one or both of the resonant frequencies which, in turn, interacts with the MEMS tags to produce a response signal. Since uncured cement has a high attenuation, only the lower resonant frequency response signal is sensed by an interrogation device, thus indicating the cement remains uncured. When the cement cures, its conductivity drops and the attenuation of the higher resonant frequency response signal drops also, thus allowing that signal to be detected by the interrogation device and indicating the cement has cured.
Patent AU-2016200034-B2 (AU)
Title: Recognition sequences for I-Crei-derived meganucleases and uses thereof
Inventor: JANTZ DEREK
IPC: C12N5/10
Filed: 2016-01-05
Granted: 2018-02-15
Abstract: H:\TRN\Intrwovn\NRPortbl\DCC\TRN\9205978_I.docx-22/12/2015 Methods of cleaving double-stranded DNA that can be recognized and cleaved by a rationally-designed, I-Crel-derived meganuclease are provided. Also provided are recombinant nucleic acids, cells, and organisms containing such recombinant nucleic acids, as well as cells and organisms produced using such meganucleases. Also provided are methods of conducting a custom-designed, I-Crel-derived meganuclease business.
Patent AU-2016204318-B2 (AU)
Title: Process for producing a particulate composition comprising crystalline alpha, alpha-trehalose di-hydrate
Inventor: SHIBUYA TAKASHI
IPC: C07H3/04
Filed: 2016-06-24
Granted: 2017-03-02
Abstract: Abstract Provided is a production method whereby it is possible to produce a powder containing crystalline trehalose dihydrate with starch as a starting material with high powder-to-starch yields. More specifically, provided is a production method for a powder containing crystalline a, a-trehalose dihydrate and having at least 98.Omass% of a, a-trehalose on an anhydrous basis, said method including: a step in which liquefied starch is subjected to the actions of a starch debranching enzyme, cyclomaltodextrin glucanotransferase, an a-glycosyl trehalose producing enzyme derived from a micro-organism belonging to the genus arthrobacter, and a trehalose releasing enzyme derived from a micro-organism belonging to the genus arthrobacter, and then to the action of glucoamylase, to obtain an a, a-trehalose containing saccharide solution; a step in which a, a-trehalose dihydrate is crystallized from the saccharide solution; and a step in which the crystallized a, a trehalose dihydrate is extracted by centrifugation, aged, and dried. The production method is characterized in that a natural or recombinant enzyme derived from a micro-organism belonging to the genus paenibacillus or a variant of such an enzyme is used as the cyclomaltodextrin glucanotransferase such that the content of a, a trehalose in the saccharide solution is over 86.Omass% on an anhydrous basis, without having to undergo a column chromatography fractionation step. 2760758v1
Patent AU-2016204936-B2 (AU)
Title: Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
Inventor: HUMAYUN MARK
IPC: A61K35/545
Filed: 2016-07-14
Granted: 2018-03-08
Abstract: Document17-14/07/2016 Disclosed herein are substrates for cell delivery to target tissues requiring treatment for various diseases that induce cell death, damage or loss of function. The substrates are configured to provide seeded cells, including stem cells, with a structural support that allows interconnection with and transmission of biological signals between the cells and the target tissue.
Patent AU-2016233495-B2 (AU)
Title: Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof
Inventor: WEST JAMES WILLIAM
IPC: G01N33/53
Filed: 2016-03-14
Granted: 2022-02-24
Abstract: The invention relates generally to antibodies that bind programmed death ligand 1 (PDL1), activatable antibodies that specifically bind to PDL1 and methods of making and using these anti-PDL1 antibodies and anti-PDL1 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
Patent AU-2016235362-B2 (AU)
Title: Antibodies to ICOS
Inventor: SAZINSKY STEPHEN
IPC: A61K39/395
Filed: 2016-03-22
Granted: 2021-12-16
Abstract: Provided herein are various embodiments relating to antibodies. Some of the embodiments include agonist antibodies that bind ICOS. Such antibodies can be used in methods to treat, for example, cancer.
Patent AU-2016253675-B2 (AU)
Title: Transmission method, transmission device, reception method, and reception device
Inventor: MURAKAMI YUTAKA
IPC: H04B7/04
Filed: 2016-11-04
Granted: 2018-11-08
Abstract: Provided is a transmission method executed by a transmission system, the transmission method comprising: generating a plurality of first transmission signals zI and a plurality of second transmission signals z2 for each slot by using any one of 5 N signal processes with respect to a plurality of first modulated signals s1 and a plurality of second modulated signals s2, the plurality of first modulated signals s1 being the same transmission data as the plurality of second modulated signals s2, N being an integer that is at least three, the N signal processes being regularly switched with a plurality of slots as one cycle; transmitting a plurality of first OFDM signals 10 from a first antenna, the plurality of first transmission signals zI being arranged in the plurality of first OFDM signals; and transmitting a plurality of second OFDM signals from a second antenna, the plurality of second transmission signals z2 being arranged in the plurality of second OFDM signals, wherein any one of the plurality of first OFDM signals including any one of the plurality of first transmission signals 15 zI generated in a first slot and any one of the plurality of second OFDM signals including any one of the plurality of second transmission signals z2 generated in the first slot are transmitted at a same frequency and time, and the plurality of first OFDM signals and the plurality of second OFDM signals each include a control symbol transmitting control information used in demodulation, the control 20 information including information indicating the N signal processes. 8366309_1 (GHMatters) P92224.AU.1
Patent AU-2016265991-B2 (AU)
Title: Signal Generation Method and Signal Generation Device
Inventor: MURAKAMI YUTAKA
IPC: H04B7/04
Filed: 2016-11-29
Granted: 2018-10-25
Abstract: The invention provides an OFDM signal generation method and apparatus, of a transmission system having a first transmitter and a second transmitter. The 5 method comprises: modulating, by the first and second transmitters, each of a plurality of coded blocks to first and second modulated signals sI, s2 respectively, the coded blocks each made up of a plurality of bits by using a predetermined error correction block coding scheme, data included in the first and second modulated signals s1, s2 being the same; inserting, by the first and second 10 transmitters respectively, one or more pilots to the first and second modulated signals sl, s2 to obtain first and second pilot-inserted signal sl',s2'; phase-changing, by the first and second transmitters respectively, while regularly varying a first and second schemes of phase change for each of a plurality of slots, the first and second pilot-inserted signal sl',s2' to obtain first and second 15 transmission signals zl,z2; and converting, by the first and second transmitters respectively, the first and second transmission signal zl,z2 to first and second OFDM signals to be transmitted from first and second antennae at a first period at a first frequency. 8455481_1 (GHMatters) P92233.AU.2 ++ E + L- EN r 4 J 4JJ 0 U o 0co m m (D (D (D I ±O 4U (a CIO C) -C < -.. - 3 Cl V (a CI + <r 4- C-4 E '-.- Co bD 2+ 42 E' E Nt _0 N N 0 co CL bJ3D (U CO. () < 4-co ca 0__ C_ (UD ( -l co
Patent AU-2016287372-B2 (AU)
Title: Control device for a medical aerosol delivery device
Inventor: PRINCE IVAN
IPC: A61M15/00
Filed: 2016-06-29
Granted: 2021-07-01
Abstract: The invention relates to a control device (10) for a medical aerosol delivery device (2), a medical aerosol delivery system (1), a method for controlling a medical aerosol delivery device (2), a computer program element for controlling such device or system, and a computer readable medium having stored such computer program element. The control device (10) for a medical aerosol delivery device (2) comprises a provision unit (11), a processing unit (12), and a control unit (13). The provision unit (11) is configured to provide inhalation length data per breath. The processing unit (12) is configured to compare the provided inhalation length data with a predetermined inhalation length threshold, and to filter provided inhalation length data below the predetermined inhalation length threshold. The control unit (13) is configured to control the medical aerosol delivery device (2) based on the filtered inhalation length data.
Patent AU-2016315025-B2 (AU)
Title: Application of genetic engineering bacterium of attenuated salmonella typhimurium in preparation of medicine for treating liver cancer
Inventor: Zhao Allan Zijian
IPC: A61K48/00
Filed: 2016-08-17
Granted: 2022-07-14
Abstract: Provided is an application of a genetic engineering bacterium of attenuated Salmonella typhimurium in preparation of medicine for treating liver cancer. The bacterium is attenuated Salmonella typhimurium VNP20009 carrying a plasmid cloned with a methionine synthase gene. Also provided is a construction method for the bacterium.
Patent AU-2016319116-B2 (AU)
Title: Cyano thienotriazolodiazepines and uses thereof
Inventor: BRADNER JAMES E
IPC: C07D495/14
Filed: 2016-09-09
Granted: 2020-10-01
Abstract: The present invention provides compounds and pharmaceutically compositions thereof. The compounds and compositions are binders of bromodomains and/or bromodomain-containing proteins (
Patent AU-2016362825-B2 (AU)
Title: Fastener driving system
Inventor: HALE TROY
IPC: B25B23/04
Filed: 2016-12-05
Granted: 2022-06-09
Abstract: A positioning assembly for a driving system, the assembly having a first jaw and a second jaw, the first jaw fixed to a driver guide tube, the second jaw fixed to the first jaw to allow one end of the first jaw to rotate away from the second jaw about a connection point, each jaw having an interior channel. The interior channel of the first jaw has an arcuate cross-section. The interior channel of the second jaw is formed from a plurality of walls including an arcuate upper wall and a sub-channel having cross-section formed by a base surface and two side walls, each side wall angled with respect to the base surface. The apparatus also includes a locking member configured to engage the second jaw when the second jaw is rotated away from the first jaw and retain the second jaw in a rotated position.
Patent AU-2016383311-B2 (AU)
Title: Bottom-to-top liquid filling system
Inventor: LAU YUK HANG
IPC: B67C3/26
Filed: 2016-12-05
Granted: 2020-10-01
Abstract: A bottom-to-top liquid filling system comprises an upper body (10) and a lower body (20). The upper body (10) comprises a fixing component (12) and comprises a lifting component (11) provided with a filling flowing channel (15) in the middle. The fixing component (12) is fixedly disposed on the inner bottom surface of the upper body (10). The lifting component (11) is disposed in the fixing component (12) and can move up and down. A flowing-through-hole (16) is formed in the inner wall of the lifting component (11). The filling flowing channel (15) passes through the bottom of the upper body (10). The lower body (20) comprises a capping plug (21), a rigid cylinder (22), an outer-ring extension tube (24), and an inner-ring extension tube (26). A spring (25) is disposed in the outer-ring extension tube (24). The rigid cylinder (22) is disposed on a top plate (24a) and is provided with a passage. The inner-ring extension tube (26) is disposed in the outer-ring extension tube (24) and communicates with the rigid cylinder (22). A bottom plate (24b) is provided with a support pillar (23), and the support pillar (23) passes through the inner-ring extension tube (26) and stretches into the rigid cylinder (22). The capping plug (21) connected to the top portion of the rigid cylinder (22) is fixedly disposed on the top portion of the support pillar (23). The outer wall of the capping plug (21) engages with the inner wall of the top portion of the lifting component (11). The filling system is unlikely to cause sprinkle and leakage, has low costs and reduces the probability of scalds.
Patent AU-2017200999-B2 (AU)
Title: Cytotoxicity-inducing therapeutic agent
Inventor: NEZU JUNICHI
IPC: C12N1/15
Filed: 2017-02-14
Granted: 2019-04-18
Abstract: CYTOTOXICITY-INDUCING THERAPEUTIC AGENT By replacing the antigen-binding domain, the present inventors discovered novel polypeptide complexes that retain BiTE's strong anti-tumor activity and excellent safety 5 properties, as well as have long half-life in blood and can damage various different target cells.
Patent AU-2017209307-B2 (AU)
Title: Compositions and methods for screening and identifying clinically aggressive prostate cancer
Inventor: HUTTENHOWER CURTIS
IPC: C12Q1/68
Filed: 2017-01-20
Granted: 2023-06-15
Abstract: The present invention provides methods for screening and diagnosing prostate cancer based on a correlation between cancer cell growth, cancer lethality or recurrence and the expression level of ZFP36 or NEDD9 and PTEN in conjunction with ZFP36. The disclosure also provides methods for screening and diagnosing prostate cancer based on a correlation between cancer lethality and the genotype of rs1910301 SNP. Also provided are methods for treating prostate cancer comprising providing a treatement or monitoring based on the expression level of ZFP36, the expression level of NEDD9, and the expression level of ZFP36 in conjunction with PTEN levels or the genotype of rs1910301 SNP.
Patent AU-2017215121-B2 (AU)
Title: Nickel containing mixed metal-oxide/carbon bulk hydroprocessing catalysts and their application
Inventor: BERGWERFF JACOB ARIE
IPC: B01J37/20
Filed: 2017-02-01
Granted: 2020-10-29
Abstract: The current invention relates a bulk catalyst precursor (i.e. no support material is added as such) comprising Ni and Mo and/or W and an organic component, wherein the molar ratio of C:(Mo+W) ranges from 1.5 to 10. The bulk catalyst precursor is prepared from a mixture of metal-precursors with an organic agent. The organic agent is partly decomposed to form a mixed metal-oxide/C phase which is in effect the bulk catalyst precursor. This bulk catalyst precursor (i) is effectively insoluble in water (ii) does not have any appreciable pore volume or surface area and (iii) does not contain a (nano)crystalline metal-oxide phase as characterized by XRD. A bulk catalyst is made from the bulk catalyst precursor.
Patent AU-2017221193-B2 (AU)
Title: Process for preparing 7H-pyrrolo (2, 3-d) pyrimidine compounds
Inventor: STUK TIMOTHY LEE
IPC: C07C309/30
Filed: 2017-02-07
Granted: 2019-03-14
Abstract: Described herein are improved processes for the preparation of the 7H-pyrrolo[2,3-d]pyrimidine compound, N-methyl-1-{trans-4-[methyl(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino]cyclohexyl}-methanesulfonamide, intermediates thereof, and veterinary acceptable salts thereof. (Formula (1))
Patent AU-2017239030-B2 (AU)
Title: Contacting system for producing an electrical connection between a primary device and a secondary device
Inventor: STOCKINGER HERMANN
IPC: H01R13/62
Filed: 2017-03-16
Granted: 2021-03-04
Abstract: A contacting system (1; 26; 33; 36; 38) for producing an electrical connection between a primary device and a secondary device, comprising a primary transmission element (2; 6; 27; 39) with multiple primary contact surfaces (3, 29); and comprising a secondary transmission element (9; 28; 34; 37; 40) with multiple secondary contact surfaces (10; 10a; 10b; 32a; 32b; 32c; 35a; 35b; 42a; 42b). Furthermore, the primary transmission element (2; 6; 27; 39) has multiple primary PE contact surfaces (4; 7; 30) and the secondary transmission element (9; 28; 34; 37; 40) has at least one secondary PE contact surface (31a, 31b; 41). An electrical connection between the primary device and the secondary device is produced by contacting of the primary transmission element (2; 6; 27; 39) and the secondary transmission element (9; 28; 34; 37; 40).
Patent AU-2017262701-B2 (AU)
Title: Method, communication system and computer program for providing information indicative of concentration of allergens in the environment
Inventor: MUZIO MASSIMILIANO
IPC: G06F17/00
Filed: 2017-05-08
Granted: 2022-06-09
Abstract: It is disclosed a method, a communication system and a computer program for providing information indicative of concentration of allergens in the environment. A person detecting a respiratory difficulty symptom (presumably due to the presence of an allergen in the environment) records information relating to the detected symptom using her/his mobile device. The recording comprises providing subjective information relating to the detected respiratory difficulty symptom via a graphical interface of the mobile device. The mobile device completes the information relating to the detected symptom with automatically generated objective information (date and time). Then, at least part of the recorded information relating to the detected symptom is shared by the mobile device on a sharing server. Any other mobile device may receive the share part of the recorded information relating to the detected symptom from the sharing server and display it on a map shown by its display.
Patent AU-2017272258-B2 (AU)
Title: Reversing system for telescopic sights, and telescopic sight having such a reversing system
Inventor: FUHRMANN LOTHAR
IPC: G02B7/10
Filed: 2017-12-07
Granted: 2023-05-04
Abstract: Main illustration: Fig. 4 
The invention relates to a reversing system (1) for telescopic sights, having a guide sleeve (10), 
an outer sleeve (20) and a mount (30) that has an optical element (32), the outer sleeve (20) 
being supported in an axially fixed and rotatable manner on the guide sleeve (10), and an inner 
cam slot (11) being realized in the guide sleeve (10), and an outer cam slot (21) being realized 
in the outer sleeve (20), the mount (30) being supported in an axially displaceable manner in the 
guide sleeve (10) and having a guide pin (50) that projects into the inner cam slot (11) and the 
outer cam slot (21), the guide pin (50) having a carrier shaft (51), on which are seated a first 
pivot bearing (60) and a second pivot bearing (61), the first pivot bearing (60) being guided 
within the outer cam slot (21), and the second pivot bearing (61) being guided within the inner 
cam slot (11), the first pivot bearing (60) and/or the second pivot bearing (61) having, in the 
centre thereof, an inner ring (62, 63) that sits on the carrier shaft (51) and an outer ring (64, 65) 
that is rotatably supported on the inner ring (62, 63). The invention additionally relates to a 
telescopic sight having such a reversing system (1).
03 
C) 
C) 
C) 
-4 
C)3 
CA C) 
CJ1 
0 
0')1 
00J 
ALA 
-----------------------------------------------------------------------------------
-- --- --- --- ---- --- --- ---- --- --- ---- --- --- --- ---- --- --- ---- ----C- 
L -- --------------------------------------------------------------------
p1----
(--4
Patent AU-2017273353-B2 (AU)
Title: Invasive medical devices including magnetic region and systems and methods
Inventor: ISAACSON S RAY
IPC: A61M25/01
Filed: 2017-05-23
Granted: 2020-04-09
Abstract: I nvasive medical device with a magnetic region (330, 630, 631, 633, L1). The magnetic region (330, 630, 631, 633, L1) can include a discontinuity (235, 335) in the magnetic region (330, 630, 631, 633, L1) providing a diameter transition, a plurality of spaced magnetic regions (430, 530, 531, 630) can be provided or the magnetic regions (430, 530, 531, 630) can be encoded with data. Systems and methods are described that include ways to read the data.